NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT03575806,Combine TACE and Autologous Tcm Immunotherapy Versus TACE Alone for HCC With MVI After Radical Resection,https://clinicaltrials.gov/study/NCT03575806,,COMPLETED,The purpose of this study is to assess the efficacy and safety of combining autologous Tcm immunotherapy and TACE in HCC patients with MVI after radical resection. Patients will be assigned either to the experimental arm to receive autologous Tcm immunotherapy and TACE or to the active comparator (TACE alone).,YES,Hepatocellular Carcinoma|Malignant Neoplasm,COMBINATION_PRODUCT: TACE plus autologous Tcm immunotherapy|PROCEDURE: TACE,"Recurrence-free Survival (RFS) Time, Recurrence-free survival was defined as the interval (in months) between hepatectomy and diagnosis of recurrence using either intrahepatic recurrence or extrahepatic metastasis., 12 months","Overall Survival (OS) Rate at 24 Months, Overall survival rate = the number of patients in TACE/TACE+Tcm group survived at 24 months/the number of total patients assigned into TACE/TACE+Tcm group., 24 months",,"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","Newish Technology (Beijing) Co., Ltd.",ALL,"ADULT, OLDER_ADULT",PHASE2,52,OTHER,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,CancerIHCAMS-HCC-Tcm,2017-01-09,2019-10-31,2019-10-31,2018-07-03,2019-12-05,2020-06-11,"Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing, 100021, China","Study Protocol, Statistical Analysis Plan, and Informed Consent Form, https://storage.googleapis.com/ctgov2-large-docs/06/NCT03575806/Prot_SAP_ICF_000.pdf"
